ANALABS

1.170

(%)

OTHERS ANALABS RESOURCES BERHAD ("Analabs" or "the Company") ACQUISITION OF QUOTED SECURITIES PURSUANT TO PARAGRAPH 9.20 OF THE MAIN MARKET LISTING REQUIREMENTS

ANALABS RESOURCES BERHAD

Type Announcement
Subject OTHERS
Description
ANALABS RESOURCES BERHAD ("Analabs" or "the Company")
ACQUISITION OF QUOTED SECURITIES PURSUANT TO PARAGRAPH 9.20 OF THE MAIN MARKET LISTING REQUIREMENTS

Pursuant to Paragraph 9.20 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, Analabs wishes to inform that the aggregate purchase consideration of quoted securities by the Group for the preceding 12 months (excluding the purchase which was previously announced on 13 March 2020 pursuant to pursuant to Paragraph 9.20), has exceeded 5% of Analabs Group's audited consolidated net assets as at 30 April 2020, details as follows:-

 

Aggregate Purchase Consideration within the preceding    :  RM13,593,973

12 months from 27 March 2020 to 26 March 2021 

 

% of the Audited Consolidated Net Assets                           : 5.31%

 

As at 26 March 2021, the investments in quotd securities held by Analabs Group are set out below:-

 

1.  Total Cost : RM135,444,468

2.  Book Value :  RM122,437,279

3.  Market Value :  RM122,437,279

 

Please refer to the attachment below for further details.

 

This announcement is dated 26 March 2021.




Please refer attachment below.

Attachments

analabs - mbb.pdf
270.8 kB



Announcement Info

Company Name ANALABS RESOURCES BERHAD
Stock Name ANALABS
Date Announced 26 Mar 2021
Category General Announcement for PLC
Reference Number GA1-26032021-00068